Latest Lilly Stories
-- Ramucirumab Plus FOLFIRI Improved Survival in Metastatic Colorectal Cancer following Progression on a Bevacizumab-Based Regimen -- INDIANAPOLIS, Sept.
INDIANAPOLIS, Sept. 9, 2014 /PRNewswire/ -- Fifty abstracts designed to advance knowledge in diabetes science will be presented Sept.
INDIANAPOLIS and RIDGEFIELD, Conn., Aug. 18, 2014 /PRNewswire/ -- The U.S.
Third product from the BI-Lilly Diabetes alliance to be approved by FDA RIDGEFIELD, Conn., and INDIANAPOLIS, Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
INDIANAPOLIS, July 24, 2014 /PRNewswire/ -- -- Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S.
INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly for Better Health(TM) program, with several innovative enhancements to
BEIJING, July 7, 2014 /PRNewswire/ -- Yabao Pharmaceutical Co, Inc.